According to the announcement issued by Northeast Pharmaceutical Group Co.,Ltd, because the export rebates of APIs Piracetam, Amantadine, Sulfadiazine decrease from 13% to 5%, the salse cost of exporting APIs rise correspondly in the second half year. It is estimated that the profit will decrease about 9.23 million Yuan this year.
Northeast Pharma said it will take some countermeasures to decrease the adverse affecion to the greatest extent, such ase adjusting the prices, optimizing the structure of products, decreasing production cost.